Patents by Inventor Daniel C. Chan

Daniel C. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAL IMPLANT WITH DISCONTINUOUS OSSEOINTIGRATIVE SURFACE
    Publication number: 20210236245
    Abstract: A medical implant includes a base portion configured for implantation into a bone of a patient. The base portion is formed from an electrically insulating and biocompatible base material with retaining features on an outer surface of the base portion for gripping the bone in the patient. A plurality of titanium bands is positioned along the outer surface of the base portion.
    Type: Application
    Filed: April 20, 2021
    Publication date: August 5, 2021
    Applicant: University of Washington
    Inventors: Alexander Pozhitzkov, James D. Bryers, Eric Lindhahl, Daniel C. Chan
  • Custom Retaining and Suction Device
    Publication number: 20210000570
    Abstract: A method of making a custom dental clamp, the method comprising producing a first clamp member using data from a scan of a patient's tooth, the first clamp member having at least one surface shaped to conform to a first surface of the tooth, producing a second clamp member using data from the scan, the scan clamp member having at least one surface shaped to conform to a second surface of the tooth, and connecting the first clamp member to the second clamp member with a resilient member.
    Type: Application
    Filed: June 30, 2020
    Publication date: January 7, 2021
    Inventors: Daniel C. Chan, Yen-Wei Chen, Pavel Vasilyuk
  • ARTIFICIAL TEETH
    Publication number: 20150374590
    Abstract: Disclosed herein are artificial teeth that include an enamel portion comprising a thermoset resin and a radio-opaque filler material distributed within the thermoset resin.
    Type: Application
    Filed: March 19, 2014
    Publication date: December 31, 2015
    Inventors: Daniel C. CHAN, Mark A. GANTER, John WATAHA, Julie HEWETT, Brandon BROWMAN, Kwok-hung CHUNG
  • Flurbiprofen analogs and methods of use in treating cancer
    Patent number: 8575170
    Abstract: Flurbiprofen analog compounds having an amino acid derivatized at the flurbiprofen alkanoic acid carboxyl group and terminating at an ester or amide group are effective in inhibiting cancer cells in vitro and inhibiting the growth of cancers in viva. The compounds and pharmaceutical compositions containing them are particularly useful for the treatment of lung, pancreatic and head and neck cancers.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: November 5, 2013
    Assignee: The Regents of the Unversity of Colorado, a body corporate
    Inventors: Lajos Gera, Daniel C. Chan, Robert S. Hodges, Paul A. Bunn
  • Use of titanium-based materials as bactericides
    Patent number: 8545820
    Abstract: Compositions containing metal ions bound into a titanate are described which have demonstrated an ability to suppress bacterial growth of a number of organisms associated with periodontal disease and caries.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: October 1, 2013
    Assignees: Savannah River Nuclear Solutions, LLC, University of Washington Center for Commercialization
    Inventors: David T. Hobbs, Mark C. Elvington, John Wataha, Whasun O. Chung, R. Bruce Rutherford, Daniel C. Chan
  • Use of Titanium-Based Materials as Bactericides
    Publication number: 20120156145
    Abstract: Compositions containing metal ions bound into a titanate are described which have demonstrated an ability to suppress bacterial growth of a number of organisms associated with periodontal disease and caries.
    Type: Application
    Filed: July 14, 2011
    Publication date: June 21, 2012
    Inventors: David T. Hobbs, Mark C. Elvington, John Wataha, Whasun O. Chung, R. Bruce Rutherford, Daniel C. Chan
  • FLURBIPROFEN ANALOGS AND METHODS OF USE IN TREATING CANCER
    Publication number: 20110275648
    Abstract: Flurbiprofen analog compounds having an amino acid derivatized at the flurbiprofen alkanoic acid carboxyl group and terminating at an ester or amide group are effective in inhibiting cancer cells in vitro and inhibiting the growth of cancers in viva. The compounds and pharmaceutical compositions containing them are particularly useful for the treatment of lung, pancreatic and head and neck cancers.
    Type: Application
    Filed: February 25, 2011
    Publication date: November 10, 2011
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Lajos GERA, Daniel C. CHAN, Robert S. HODGES, Paul A. BUNN
  • EXPRESSION OF KIR IN HUMAN CANCER CELLS AS A BIOMARKER FOR IMMUNO-ESCAPE AND CANCER METASTASIS
    Publication number: 20110091482
    Abstract: The present invention is based on the finding that the level of KIR expression in a cancer cell is significant with regard to tumor invasion and metastasis. Therefore, the present invention concerns methods and compositions for evaluating cancer in a patient based on KIR protein or mRNA expression. The invention also provides methods and compositions for treating cancer using a KIR inhibitor and methods of screening for KIR inhibitors.
    Type: Application
    Filed: April 9, 2009
    Publication date: April 21, 2011
    Applicant: The Regents of the University of Colorado, A Body Corporate
    Inventors: Daniel C. Chan, Di Zheng, Zhiyong Zhang
  • Cytolytic bradykinin antagonists
    Patent number: 5849863
    Abstract: The present invention provides bradykinin antagonists effective to inhibit cancer cell growth. Also provided are methods of inhibiting lung cancer cell growth by administering a therapeutically effective amount of a dimerized bradykinin antagonist.
    Type: Grant
    Filed: September 8, 1995
    Date of Patent: December 15, 1998
    Assignees: University of Colorado, Cortech, Inc.
    Inventors: John M. Stewart, Daniel C. Chan, Eric T. Whalley, Lajos Gera